Unorthodox alternative therapies marketed to treat Lyme disease.
about
Serious Bacterial Infections Acquired During Treatment of Patients Given a Diagnosis of Chronic Lyme Disease - United States.Lyme disease: why the controversy?Editorial commentary: what constitutes appropriate treatment of post-Lyme disease symptoms and other pain and fatigue syndromes?NF‑κB is a key modulator in the signaling pathway of Borrelia burgdorferi BmpA‑induced inflammatory chemokines in murine microglia BV2 cells.Lyme borreliosis
P2860
Unorthodox alternative therapies marketed to treat Lyme disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Unorthodox alternative therapies marketed to treat Lyme disease.
@ast
Unorthodox alternative therapies marketed to treat Lyme disease.
@en
type
label
Unorthodox alternative therapies marketed to treat Lyme disease.
@ast
Unorthodox alternative therapies marketed to treat Lyme disease.
@en
prefLabel
Unorthodox alternative therapies marketed to treat Lyme disease.
@ast
Unorthodox alternative therapies marketed to treat Lyme disease.
@en
P2093
P2860
P356
P1476
Unorthodox alternative therapies marketed to treat Lyme disease
@en
P2093
Edward McSweegan
Eugene D Shapiro
Gary P Wormser
Paul G Auwaerter
Paul M Lantos
Phillip J Baker
P2860
P304
P356
10.1093/CID/CIV186
P407
P577
2015-04-06T00:00:00Z